Prevalence, Management, and Comorbidities of Adults With Atrial Fibrillation in the United States, 2019 to 2023
2024

Prevalence and Management of Atrial Fibrillation in the U.S. (2019-2023)

Sample size: 4834977 publication 10 minutes Evidence: high

Author Information

Author(s): Oltman Connor G., Kim Taehyung P., Lee James W.Y., Lupu John D., Zhu Ruoqing, Moussa Issam D.

Primary Institution: Carle Illinois College of Medicine, University of Illinois Urbana-Champaign

Hypothesis

What is the current prevalence and management of atrial fibrillation in the United States?

Conclusion

The study highlights a significant prevalence of atrial fibrillation in the U.S., particularly among older adults and certain demographic groups, with many patients not receiving necessary anticoagulation treatment.

Supporting Evidence

  • The overall prevalence of atrial fibrillation was found to be 3.89%.
  • 30% of individuals with atrial fibrillation did not receive anticoagulant medication.
  • Rural areas reported a higher prevalence of atrial fibrillation (5.29%) compared to urban areas (3.66%).
  • Patients aged 90 and older had a prevalence of 24.58%.

Takeaway

A lot of people in the U.S. have a heart condition called atrial fibrillation, especially older folks, and many of them aren't getting the medicine they need to stay safe.

Methodology

This was a retrospective cohort study using data from Epic’s Cosmos platform, analyzing over 259 million patient records.

Potential Biases

The study may be biased towards data from urban or suburban health facilities due to the predominance of Epic's EHR system.

Limitations

Potential data entry errors and inconsistencies in problem list usage may affect data accuracy; underrepresentation of smaller health care units and asymptomatic patients may limit findings.

Participant Demographics

Mean age of participants was 76 years; 55.43% were male and 83.05% were non-Hispanic White.

Statistical Information

Confidence Interval

95% CI

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.jacadv.2024.101330

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication